Drug Approval | March 01, 2024
Biocon Biologics secures US market entry date for Bmab 1200
The agreement licenses the company to launch in the United States, in February 2025, once approved by the U.S. FDA
The agreement licenses the company to launch in the United States, in February 2025, once approved by the U.S. FDA
Eugia Pharma Specialities restarts production at terminally sterilized product lines
The U.S. FDA recently approved Xolair as the first and only medicine for children and adults with one or more food allergies
Academic and Policy Research to get further boost, RIS will bring forth Ayush Service Sector report soon
Patients visiting OPD sections of hospitals use their Ayushman Bharat Health Account (ABHA) to get instant tokens to save time spent in registration queues
‘Unmask Anemia’ aims to simplify assessment of iron deficiency anemia risk with an easy online self-test based on common signs and symptoms
Varenicline is indicated for smoking cessation in adults
The contract awarded to Kilitch Estro Biotech PLC entails the supply of pharmaceuticals with an order size amounting to US$ 9.13 million
Both the Ministries signed MoU for anaemia control among adolescent girls using Ayurveda interventions
VeerHealth Care will be raising Rs. 8 crores through bank borrowings
Subscribe To Our Newsletter & Stay Updated
